What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?
J Hematop
; 17(2): 71-89, 2024 Jun.
Article
en En
| MEDLINE
| ID: mdl-38683440
ABSTRACT
The classification of tumors is essential in the diagnosis and clinical management of patients with malignant neoplasms. The World Health Organization (WHO) provides a globally applicable classification scheme of neoplasms and it was updated several times. In this review, we briefly outline the cornerstones of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours on lymphoid neoplasms. As is adopted throughout the 5th edition of the WHO classification of tumors of all organ systems, entities are listed by a hierarchical system. For the first time, tumor-like lesions have been included in the classification, and modifications of nomenclature for some entities, revisions of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities are presented along with mesenchymal lesions specific to the stroma of lymph nodes and the spleen. In addition to specific outlines on constitutional and somatic genetic changes associated with given entities, a separate chapter on germline predisposition syndromes related to hematologic neoplasms has been added.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Organización Mundial de la Salud
/
Linfoma de Células B
/
Linfoma de Células T
/
Neoplasias de los Tejidos Conjuntivo y Blando
/
Linfoma Extranodal de Células NK-T
Límite:
Humans
Idioma:
En
Revista:
J Hematop
Año:
2024
Tipo del documento:
Article